EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytokine Networks and Heart Failure Outcomes: CA125 as a Bridge Between Congestion and Inflammation

Enrique Santas, Arancha Martí-Martínez iD, Sandra Villar iD, Rafael de la Espriella, Enrique Rodriguez-Borja, Elena Revuelta-López iD, Arantxa González-Miqueo, Antoni Bayés-Genís iD, Juan Sanchis iD, Julio Núñez iD

International Journal of Molecular Sciences · 29.09.2025 · 26 (19) · 9527

DOI: 10.3390/ijms26199527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.09.2025. Verfasst von Enrique Santas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria (INCLIVA), 46010 Valencia, Spain. Hauptthemen laut MEDLINE: CA-125 Antigen, Heart Failure, Inflammation, Cytokines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIBER CV (Madrid, Spain).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation and congestion constitute fundamental mechanisms underlying heart failure (HF). Carbohydrate Antigen 125 (CA125) is a well-established biomarker in HF, primarily associated with congestion, but also it may act as a functional ligand amplifying the inflammatory response in HF. Our aim was to evaluate the potential modulatory effect of CA125 on inflammation, assessed by a set of cytokines (interleukin [IL]-6, IL-10, IL-1β, and tumor necrosis factor [TNF]). We prospectively included 284 patients admitted for acute HF in which cytokines and CA125 were assessed at admission. Study endpoints were all-cause mortality and total HF rehospitalizations. At a median follow-up of 4.2 years (interquartile range: 1.3–7.5), a total of 211 patients (74.3%) died, and 117 patients (41.2%) experienced 249 HF readmissions. In the multivariable analysis, a significant interaction between IL-6 and IL-10 and CA125 was observed for both outcomes (p-value for interactions < 0.05 for all comparisons). Among patients with CA125 > 35 U/mL, both IL-6 and IL-10 showed a positive, linear relationship with the risk of death or HF readmissions. In contrast, we did not find a significant association in patients with CA125 ≤ 35 U/mL. In conclusion, the association between IL-6 and IL-10 with long-term adverse events was significantly modulated by CA125 status, being significantly associated with poor prognosis only when CA125 was upregulated. These findings support a potential modulatory role for CA125 in the inflammatory response in HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CA-125 AntigenHeart FailureInflammationCytokinesMembrane ProteinsHumansMaleFemaleAgedMiddle AgedBiomarkersPatient ReadmissionProspective StudiesPrognosisInterleukin-10Interleukin-6Aged, 80 and over

Stichwörter der Autor:innen

antigen carbohydrate 125cytokinesheart failureinflammation

Substanzen

CA-125 AntigenCytokinesBiomarkersInterleukin-10MUC16 protein, humanInterleukin-6Membrane Proteins

Autor:innen und Institutionen

  • Cardiology Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria (INCLIVA), 46010 Valencia, Spain.
  • Faculty of Medicine and Dentistry, Universitat de València, 46010 Valencia, Spain.
  • Clinical Biochemistry Department, Hospital Clinico Universitario de Valencia, 46010 Valencia, Spain.
  • Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.
  • Cardiology Department, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.
  • Program of Cardiovascular Disease, CIMA Universidad de Navarra, Department of Cardiology and Cardiac Surgery, Clínica Universidad de Navarra and IdiSNA, 31008 Pamplona, Spain.

ORCID-Profile: Arancha Martí-Martínez, Sandra Villar, Elena Revuelta-López, Antoni Bayés-Genís, Juan Sanchis, Julio Núñez

Förderung

  • CIBER CV (Madrid, Spain)

Zitieren

APA

Santas, E., Martí-Martínez, A., Villar, S., de la Espriella, R., Rodriguez-Borja, E., Revuelta-López, E., González-Miqueo, A., Bayés-Genís, A., Sanchis, J., & Núñez, J. (2025). Cytokine Networks and Heart Failure Outcomes: CA125 as a Bridge Between Congestion and Inflammation. International Journal of Molecular Sciences, 26(19), 9527. https://doi.org/10.3390/ijms26199527

Vancouver

Santas E, Martí-Martínez A, Villar S, de la Espriella R, Rodriguez-Borja E, Revuelta-López E, et al. Cytokine Networks and Heart Failure Outcomes: CA125 as a Bridge Between Congestion and Inflammation. International Journal of Molecular Sciences. 2025;26(19):9527. doi:10.3390/ijms26199527

BibTeX
@article{Santas2025,
  author = {Santas, Enrique and Martí-Martínez, Arancha and Villar, Sandra and de la Espriella, Rafael and Rodriguez-Borja, Enrique and Revuelta-López, Elena and González-Miqueo, Arantxa and Bayés-Genís, Antoni and Sanchis, Juan and Núñez, Julio},
  title = {Cytokine Networks and Heart Failure Outcomes: CA125 as a Bridge Between Congestion and Inflammation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {19},
  pages = {9527},
  doi = {10.3390/ijms26199527}
}
Kostenlos starten →